Gene Therapy for Regenerative Medicine.

Area of Science:

• Regenerative Medicine
• Gene Therapy
• Tissue Engineering

Background:

• Recent decades show significant progress in biological methods for human tissue regeneration.
• Stem cell research, gene therapy, and tissue engineering are key drivers of this advancement.
• Clinical application of gene therapy faces technical challenges, particularly regarding safety and efficacy.

Purpose of the Study:

• To critically review gene therapy approaches for regenerative medicine.
• To highlight the potential of non-viral gene transfection agents as safer alternatives to viral vectors.
• To explore the integration of tissue engineering technologies for enhanced in vivo gene delivery and function.

Main Methods:

• Review of current literature on gene therapy and regenerative medicine.
• Analysis of viral and non-viral gene delivery systems.
• Evaluation of tissue engineering strategies for therapeutic gene delivery.

Main Results:

• Non-viral gene transfection agents show promise for treating genetic and acquired diseases, offering potential safety advantages over viral vectors.
• Enhancing the efficiency of non-viral vectors to match viral vector performance is a key research focus.
• Tissue engineering offers a promising avenue to improve the control over the in vivo location and function of administered genes.

Conclusions:

• Integrating tissue engineering with gene therapy can overcome limitations of current viral and non-viral approaches.
• Further development of non-viral vectors and tissue engineering strategies is crucial for advancing regenerative medicine.
• Controlling gene delivery and function in vivo is essential for successful therapeutic outcomes in regenerative medicine.